Cite
Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
MLA
Michelfelder, M., et al. “Interstitial Lung Disease Increases Mortality in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension without Affecting Hemodynamics and Exercise Capacity.” Clinical Rheumatology, vol. 36, no. 2, Feb. 2017, pp. 381–90. EBSCOhost, https://doi.org/10.1007/s10067-016-3504-6.
APA
Michelfelder, M., Becker, M., Riedlinger, A., Siegert, E., Drömann, D., Yu, X., Petersen, F., & Riemekasten, G. (2017). Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity. Clinical Rheumatology, 36(2), 381–390. https://doi.org/10.1007/s10067-016-3504-6
Chicago
Michelfelder, M, M Becker, A Riedlinger, E Siegert, D Drömann, X Yu, F Petersen, and G Riemekasten. 2017. “Interstitial Lung Disease Increases Mortality in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension without Affecting Hemodynamics and Exercise Capacity.” Clinical Rheumatology 36 (2): 381–90. doi:10.1007/s10067-016-3504-6.